Cognitive assessment in patients with Hepatitis C submitted to treatment with Sofosbuvir and Simeprevir or Daclatasvir

Gascon, Maria Rita Polo; Benute, Glaucia Rosana Guerra; Macedo, Elizeu Coutinho; Capitão, Claudio Garcia; Vidal, José Ernesto; Smid, Jerusa; Marcusso, Rosa Maria Nascimento; Lucia, Mara Cristina Souza de; Oliveira, Augusto César Penalva de; Diament, Décio.
Arq. neuropsiquiatr ; 78(6): 342-348, June 2020. tab
Artigo Inglês | SES-SP, SES SP - Instituto de Infectologia Emílio Ribas, SES-SP | ID: biblio-1102258

Documentos relacionados

  1. Using Community Paramedicine to Treat Hepatitis C Virus in Upstate South Carolina.
  2. Assessing the proportion of patients with hepatitis C treated before and after initiation of an ambulatory pharmacist-led hepatitis C program: A retrospective analysis.
  3. Selecting a theoretical framework to explore the social and cognitive uncertainty that hepatitis C treatment represents for people who inject drugs.
  4. Health-related quality of life in patients aged 6-18 years with chronic hepatitis C treated with sofosbuvir/velpatasvir.
  5. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study.
  6. Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH).
  7. Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment.
  8. Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis.
  9. A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community-based testing campaign.
  10. Rising Lysophosphatidylcholine Levels Post-Hepatitis C Clearance.